NOVOLOG
- Product NDC
- 0169-2100
- 11-digit product format
- 001692100
- Labeler code
- 0169
- Product ID
- 0169-2100_de82c22d-ea25-44ef-8bcd-c3cda9e84e59
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- insulin aspart
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Novo Nordisk
- Application
- BLA020986
- Marketing category
- BLA
- Marketing start
- 2001-08-27
- Substance
- INSULIN ASPART
- Active strength
- 100 [iU]/mL
- Pharmacologic classes
- Insulin Analog [EPC], Insulin [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NOVOLOG
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| INSULIN ASPART | 100 [iU]/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D933668QVX, 059QF0KO0R |
| Rxcui | 311040, 351926, 1653196, 1653198, 1653202, 1653204 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0169-2100-11 | NOVOLOG | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 34 |
| 0169-2100-11 | NOVOLOG | 10 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 10 | | 34 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| INSULIN ASPART | ACTIVE INGREDIENT | D933668QVX | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| INSULIN ASPART | ACTIVE MOIETY | D933668QVX | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| METACRESOL | INACTIVE INGREDIENT | GGO4Y809LO | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| PHENOL | INACTIVE INGREDIENT | 339NCG44TV | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| SODIUM PHOSPHATE, DIBASIC, DIHYDRATE | INACTIVE INGREDIENT | 94255I6E2T | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
| ZINC | INACTIVE INGREDIENT | J41CSQ7QDS | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION [NOVO NORDISK] | 19 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0169-2100 | NOVOLOG (INSULIN ASPART) INJECTION, SOLUTION INSULIN DILUTING MEDIUM FOR NOVOLOG (WATER INJECTION) INJECTION, SOLUTION [NOVO NORDISK] | 34 | Current NDC, Legacy NDC, 2 package rows | 20250122_3a1e73a2-3009-40d0-876c-b4cb2be56fc5.zip |
DailyMed RxNorm Mappings#
RxCUI, RxNorm string, TTY table| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|
| 1653196 | insulin aspart 100 UNT/ML in 3 ML Cartridge | PSN | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653202 | insulin aspart 100 UNT/ML in 3 ML Pen Injector | PSN | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 311040 | insulin aspart 100 UNT/ML Injectable Solution | PSN | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653198 | NovoLOG 100 UNT/ML in 3 ML Cartridge | PSN | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653204 | NovoLOG 100 UNT/ML in 3 ML Pen Injector | PSN | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 351926 | NovoLOG 100 UNT/ML Injectable Solution | PSN | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653198 | 3 ML insulin aspart, human 100 UNT/ML Cartridge [NovoLog] | SBD | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653204 | 3 ML insulin aspart, human 100 UNT/ML Pen Injector [NovoLog] | SBD | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 351926 | insulin aspart, human 100 UNT/ML Injectable Solution [NovoLog] | SBD | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653196 | 3 ML insulin aspart, human 100 UNT/ML Cartridge | SCD | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653202 | 3 ML insulin aspart, human 100 UNT/ML Pen Injector | SCD | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 311040 | insulin aspart, human 100 UNT/ML Injectable Solution | SCD | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653198 | 3 ML NovoLog 100 UNT/ML Cartridge | SY | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653204 | 3 ML NovoLog 100 UNT/ML Pen Injector | SY | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 311040 | insulin analog, aspart 100 UNT/ML Injectable Solution | SY | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653196 | insulin, aspart, human 100 UNT/ML per 3 ML Cartridge | SY | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653202 | insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector | SY | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 351926 | NovoLog 100 UNT/ML Injectable Solution | SY | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653204 | NovoLog FlexPen 100 UNT/ML per 3 ML Pen Injector | SY | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
| 1653204 | NovoLog FlexTouch 100 UNT/ML per 3 ML Pen Injector | SY | 3a1e73a2-3009-40d0-876c-b4cb2be56fc5 | 34 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0169-2100-11 | 00169210011 | 1 VIAL, GLASS in 1 CARTON (0169-2100-11) / 10 mL in 1 VIAL, GLASS | 2021-05-25 | 0000-00-00 | No | No | Current |